Literature DB >> 16926404

Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague.

Nadine Lemaître1, Florent Sebbane, Daniel Long, B Joseph Hinnebusch.   

Abstract

The virulence of the pathogenic Yersinia species depends on a plasmid-encoded type III secretion system that transfers six Yop effector proteins into host cells. One of these proteins, YopJ, has been shown to disrupt host cell signaling pathways involved in proinflammatory cytokine production and to induce macrophage apoptosis in vitro. YopJ-dependent apoptosis in mesenteric lymph nodes has also been demonstrated in a mouse model of Yersinia pseudotuberculosis infection. These results suggest that YopJ attenuates the host innate and adaptive immune response during infection, but the role of YopJ during bubonic plague has not been completely established. We evaluated the role of Yersinia pestis YopJ in a rat model of bubonic plague following intradermal infection with a fully virulent Y. pestis strain and an isogenic yopJ mutant. Deletion of yopJ resulted in a twofold decrease in the number of apoptotic immune cells in the bubo and a threefold increase in serum tumor necrosis factor alpha levels but did not result in decreased virulence, systemic spread, or colonization levels in the spleen and blood. Our results indicate that YopJ is not essential for bubonic plague pathogenesis, even after peripheral inoculation of low doses of Y. pestis. Instead, the effects of YopJ appear to overlap and augment the immunomodulatory effects of other Y. pestis virulence factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926404      PMCID: PMC1594864          DOI: 10.1128/IAI.00219-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

Review 1.  Functions of the Yersinia effector proteins in inhibiting host immune responses.

Authors:  Lorena Navarro; Neal M Alto; Jack E Dixon
Journal:  Curr Opin Microbiol       Date:  2005-02       Impact factor: 7.934

2.  YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells.

Authors:  L E Palmer; A R Pancetti; S Greenberg; J B Bliska
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

3.  Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death.

Authors:  D M Monack; J Mecsas; N Ghori; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

4.  Yersinia enterocolitica promotes deactivation of macrophage mitogen-activated protein kinases extracellular signal-regulated kinase-1/2, p38, and c-Jun NH2-terminal kinase. Correlation with its inhibitory effect on tumor necrosis factor-alpha production.

Authors:  K Ruckdeschel; J Machold; A Roggenkamp; S Schubert; J Pierre; R Zumbihl; J P Liautard; J Heesemann; B Rouot
Journal:  J Biol Chem       Date:  1997-06-20       Impact factor: 5.157

5.  Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection.

Authors:  A Boland; G R Cornelis
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

6.  YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK.

Authors:  L E Palmer; S Hobbie; J E Galán; J B Bliska
Journal:  Mol Microbiol       Date:  1998-03       Impact factor: 3.501

Review 7.  The virulence plasmid of Yersinia, an antihost genome.

Authors:  G R Cornelis; A Boland; A P Boyd; C Geuijen; M Iriarte; C Neyt; M P Sory; I Stainier
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

8.  The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity.

Authors:  K Schesser; A K Spiik; J M Dukuzumuremyi; M F Neurath; S Pettersson; H Wolf-Watz
Journal:  Mol Microbiol       Date:  1998-06       Impact factor: 3.501

9.  Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production.

Authors:  K Ruckdeschel; S Harb; A Roggenkamp; M Hornef; R Zumbihl; S Köhler; J Heesemann; B Rouot
Journal:  J Exp Med       Date:  1998-04-06       Impact factor: 14.307

10.  Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice.

Authors:  D M Monack; J Mecsas; D Bouley; S Falkow
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

View more
  40 in total

1.  Beyond pattern recognition: five immune checkpoints for scaling the microbial threat.

Authors:  J Magarian Blander; Leif E Sander
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

2.  Transcriptomic and innate immune responses to Yersinia pestis in the lymph node during bubonic plague.

Authors:  Jason E Comer; Daniel E Sturdevant; Aaron B Carmody; Kimmo Virtaneva; Donald Gardner; Dan Long; Rebecca Rosenke; Stephen F Porcella; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

3.  A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system.

Authors:  Igor E Brodsky; Noah W Palm; Saheli Sadanand; Michelle B Ryndak; Fayyaz S Sutterwala; Richard A Flavell; James B Bliska; Ruslan Medzhitov
Journal:  Cell Host Microbe       Date:  2010-05-20       Impact factor: 21.023

4.  Redundant and Cooperative Roles for Yersinia pestis Yop Effectors in the Inhibition of Human Neutrophil Exocytic Responses Revealed by Gain-of-Function Approach.

Authors:  Amanda R Pulsifer; Aruna Vashishta; Shane A Reeves; Jennifer K Wolfe; Samantha G Palace; Megan K Proulx; Jon Goguen; Sobha R Bodduluri; Bodduluri Haribabu; Silvia M Uriarte; Matthew B Lawrenz
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

5.  Tn5AraOut mutagenesis for the identification of Yersinia pestis genes involved in resistance towards cationic antimicrobial peptides.

Authors:  Jitao Guo; Manoj K M Nair; Estela M Galván; Shu-Lin Liu; Dieter M Schifferli
Journal:  Microb Pathog       Date:  2011-05-07       Impact factor: 3.738

6.  Amino acid substitutions in LcrV at putative sites of interaction with Toll-like receptor 2 do not affect the virulence of Yersinia pestis.

Authors:  Wei Sun; Roy Curtiss
Journal:  Microb Pathog       Date:  2012-07-24       Impact factor: 3.738

7.  Neutrophils are resistant to Yersinia YopJ/P-induced apoptosis and are protected from ROS-mediated cell death by the type III secretion system.

Authors:  Justin L Spinner; Keun Seok Seo; Jason L O'Loughlin; Jennifer A Cundiff; Scott A Minnich; Gregory A Bohach; Scott D Kobayashi
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

8.  Regulatory mechanisms underlying sepsis progression in patients with tumor necrosis factor-α genetic variations.

Authors:  Yangzhou Liu; Ning Han; Qinchuan Li; Zengchun Li
Journal:  Exp Ther Med       Date:  2016-05-04       Impact factor: 2.447

9.  Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages.

Authors:  Betty L Noel; Sarit Lilo; Daniel Capurso; Jim Hill; James B Bliska
Journal:  Clin Vaccine Immunol       Date:  2009-08-26

10.  Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague.

Authors:  Ayelet Zauberman; Avital Tidhar; Yinon Levy; Erez Bar-Haim; Gideon Halperin; Yehuda Flashner; Sara Cohen; Avigdor Shafferman; Emanuelle Mamroud
Journal:  PLoS One       Date:  2009-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.